<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 355 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page354.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=355">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 355 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 355</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=355"><img src="../thumb/355.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>318 / 2020-04                     Vitamins, Tonics, Minerals and Electrolytes / Amino-Acids / Special Foods - 20.4 / 21 / 22
   Dosage: Indiv.accord.to cause/degree of hypokalaem. Admin.   Drug interactions: Incompat.addit: Sod.warfar., Vit.B12, soda bic.,   thrombophlebit., septicaemia, loc.irrit.at inj.site, overload.syndr.,
   6-12 tabs. dly.in sev.div.dos., not more than 2 tabs in sngl.dos.  kanamycin sulph., novobiocin sod.  hyperhydrat., pulm.oed.
   Contraindications: Hyperkalaem., untreat. Addison’s dis., hy-  Special precautions: Monit.pts.on coumarin derivats.closely, do
   poreninaem., hypoaldosteronism, metab.acidos., heat cramps   NUTRIFLEX LIPID PERI, B Braun [P/S]  not mix/infuse concomit.with other sols., caut.in cases of incr.ser.
   & ac.dehydrat., sev.liv. dis., GI ulcerat./obstruct., ren.insuffic.,   Each 1875 (2500) ml: contains Glucose (anhydr.) 120,0 (160,0) g   osmolarit. /imp.card.or ren.funct., monit./correct disturbs.of fluid,
   concom.K-spar.diurets., concom.K-supplem./IV K, safety in pregn.&   equiv.to glucose monohydr. 132(176) g; Na dihydrog.phosph. di-  electrol./acidbase bal.bef.start of infus., rapid infus.can lead to
   lactat.not est., safety & effic.in childr.not est.  hydr. 1,755 (2,340) g; Zn acet.dihydr. 9,938 (13,250) mg; Medium-  fluid overload with patholog. ser.electrol.conc./hyperhydrat./pulm.
   Side effects: Hyperkalaem., prurit., skin rash, urticar., paraesthes.  chain triglycerid. 37,5 (50,0) g; Soybean oil 37,5 (50,0) g; Isoleucine   oed., monit.ser.triglycer./bld.gluc.conc., interrupt infus.with S&S of
   of extremit., musc.weakn.& paralys., GI disturbs.incl.perforat.&   3,51 (4,68) g; Leucine 4,70 (6,26) g; Lysine 3,39 (4,52) g equiv.to ly-  anaphylact.react., reduc/ interrupt dos. if bld.gluc.conc.&gt; 14 mmol/L
   ulcerat., hypotens., card.dysrhythm., heart block & card. arrest.  sine HCl 4,26 (5,68) g; Methionine 2,94 (3,92) g; Phenylalanine 5,27   (250 mg/ dl), suppl.appropr.replacem.of trace elem. & vits. dur.long-
   Special precautions: Poss.hyperkalaem.& card. arrest in pts.with   (7,02) g; Threonine 2,73 (3,64) g; Tryptophan 0,86 (1,14) g; Valine   term.admin., do not giv. simultan.with bld.in same infus.set., fat cont.
   imp.K-excret., reg.electrol.& K monit.esp.dur. prolong.ther./condits.  3,90 (5,20) g; Arginine 4,05 (5,40) g; Histidine 1,88 (2,50) g equiv.to   may interf.with cert.lab.meas.
               +
   with hyperkalaem. risk, withdr.ther.if GI sympts.pres.as poss.indic,.  histidine HCl monohydr. 2,54 (3,38) g; Alanine 7,28 (9,70) g; Aspartic   Drug interactions: Heparin in clin.dos.caus. trans.lipoprot.li-
   of GIT ulcerat./perforat., oesophag. stasis, pept./gastr.ulc., delay.  acid 2,25 (3,00) g; Glutamic acid 5,25 (7,00) g; Glycine 2,48 (3,30) g;   pase releas.into circulat.result.in init.incr.plasma lipolys.follow.by
   intestin.transit., intestin. ischaem., concom.ACE inhibit., concom.   Proline 5,10 (6,80) g; Serine 4,50 (6,00) g; NaOH 1,20 (1,60) g; NaCl   trans.triglycer. clear.decr, soybean oil may interf.with therap. eff.
   meds.that incr.ser.K-conc., elderly, ren./ adrenocortic. insuffic.,   1,622 (2,162) g; Na acet.trihydr. 0,816 (1,088) g; K acet. 4,415 (5,886)   of coumarin derivativ
   heart dis., GI ulcerat./ obstruct. hist., not advis.in pts.with osto-  g; Mg acet. tetrahydr. 0,966 (1,288)g; CaCl dihydr. 0,662 (0,882) g.
   mies as transit time poss.alt., ac.dehydrat., heat cramps, extens.   Indications: Supply of dly.requirem.of energy, essent. fatty acids,   NUTRIFLEX LIPID SPECIAL, B Braun [P/S]
                   +
   tiss.destruct.as with burns, concom. K -spar. diuret., med.known   amino acids, electrol. & fluids dur. parenter.nutrit.for pts.with   Each 625 ml contains: Glucose (anhydr.) 90,0 g equiv.to glucose
   to cause hypomagnesaem.      mild to mod.sev. catabol. when oral/enter.nutrit.imposs./insuffic/   monohydr. 99,0 g; Na dihydrog. phosph.dihydr. 1,56 g; Zn acetat.
                       +
                            +
   Drug interactions: Caut.with meds incr.ser. K  conc. eg K -spar.  contra-indicat.  dihydr. 4,39 mg; Medium-chain triglycerides 12,5 g; Soybean oil
                     +
   diuret./ACE inhibit/cyclospor./ meds. cont.K -salts such as penicill./  (S3) IV INFUS. 41/25/0757.  12,5 g; Isoleucine 2,06 g; Leucine 2,74 g; Lysine HCl 2,49 g equiv.to
   digox./Li/ NSAID’s/hepar.& beta-block.  716310-001, 1 875 ml, R1 344,71  lysine 1,99 g; Methionine 1,71 g; Phenylalanine 3,08 g; Threonine
                                716311-001, 2 500 ml, R1 792,93
                                                              1,59 g; Tryptophan 0,50 g; Valine 2,26 g; Arginine 2,37 g; Histidine
   ZYMAFLUOR, (Mylan) Takeda [P/S]  Dosage: For IV infus,admin.continuous.at max. infus.rate of 2,5 ml/  HCl monohydrate 1,48 g equiv.to histidine 1,10 g; Alanine 4,25 g;
   Sodium fluoride equiv.to fluoride.  kg body weight/hr, indiv.dose accord.to pt.requirm., treatm.should   Aspartic acid 1,32 g; Glutamic acid 3,07 g; Glycine 1,45 g; Proline 2,98
   Indications: Prevent.of dent.caries.  not exceed 7 days.   g; Serine 2,63 g; NaOH 0,732 g; Nacl 0,237 g; Na acet. trihydr. 0,157
   (S1) TABS, [P/S] E/24/728.   Max.dly.dose: 40 ml/kg body weight.  g; K acet. 2,306 g; Mg acet.tetrahydr. 0,569 g; CaCl dihydr. 0,390 g.
   779482-018: 0,25 mg, 150, R62,54  Ref.to prod.lit.for sol.prep.  Each 1250 ml contains: Glucose (anhydr.) 180,0 g equiv.to glucose
   779482-026: 0,25 mg, 400, R166,91  Contraindications: Disturbs.of amino acid/lipid metabol., hyper-  monohydr. 198,0 g; Na dihydrog. phosph.dihydr. 3,12 g; Zn acetat.
   (S1) DROPS, [P/S] Y/24/394. 4 drops=0,25 mg.  kalaem., hypernatraem., unstab. metabol. e.g. sev.post aggress.syn-  dihydr. 8,78 mg; Medium-chain triglycerides 25,0 g; Soybean oil
   835226-018: 20 ml, R45,07    dr./unstabilis. diabet.mellit./coma of unknown orig., hyperglycaem.   25,0 g; Isoleucine 4,11 g; Leucine 5,48 g; Lysine HCl 4,98 g equiv.to
   Dosage: Beg.admin.in early childh. Suck slow.in mouth as soon   not respond.to insul.doses up to 6 unit insul./hr., acidos., intrahepat.  lysine 3,98 g; Methionine 3,42 g; Phenylalanine 6,15 g; Threonine
   as age permits. Do not exceed recomm.dos.  cholestas., sev. hepat./ren.insuffic., manifest card.insuffic., aggrav.   3,18 g; Tryptophan 1,00 g; Valine 4,51 g; Arginine 4,73 g; Histidine
   Admin.accord.to fluoride conc.of drink.water. See prod.lit..  haemorrh.diathes., ac.myocard.infarct.& stroke/thromboembol./lipid   HCl monohydrate 2,96 g equiv.to histidine 2,19 g; Alanine 8,49 g; As-
   Contraindications: Kidn.dis., water fluoride conc. to be determin.  embol., known hypersens. to egg/soy prot., childr. &lt; 2yrs, unstable   partic acid 2,63 g; Glutamic acid 6,125 g; Glycine 2,89 g; Proline 5,95
   bef.admin., regions which fluoridate.  circulat.stat., inadeq.cellul. O 2 supply, fluid overload/ overhydrat.,   g; Serine 5,25 g; NaOH 1,464 g; Nacl 0,473 g; Na acet. trihydr. 0,313
   Side effects: Mottled tooth enamel/ osteoscleros./ joint pain &   electrol./fluid bal.disturb., ac. pulm.oed./decompensat.card.insuf-  g; K acet. 4,611 g; Mg acet.tetrahydr. 1,137 g; CaCl dihydr. 0,779 g.
   -stiffn/limit.movem.& crippling deform.with ingest.of excess.amnts.  fic., pregn.& lactat.as safety & effic.not est.  Each 1875 ml contains: Glucose (anhydr.) 270,0 g equiv.to glucose
   Special precautions: Supplement.not recomm. if fluor.conc.more   Side effects: Flush.,incr.temp., cold feel., shiver., headache, loss   monohydr. 297,0 g; Na dihydrog. phosph.dihydr. 4,68 g; Zn acetat.
   than 0,7 mg/l, allow for fluor. from other sources, do not admin.with   of appet., hyperglycaem., bld. disords., N&V, resp.distr., back/  dihydr. 13,17 mg; Medium-chain triglycerides 37,5 g; Soybean oil
   milk/diary product/ antacids contain. Ca, Mg or Al.  chest/bone/ lumb. area pain, BP chang., hypersens.reacts, cyanos.,   37,5 g; Isoleucine 6,16 g; Leucine 8,22 g; Lysine HCl 7,46 g equiv.to
   Drug interactions: Ca, Mg & Al.inhibit.absorpt.  thrombophlebit., septicaemia, loc.irrit.at inj.site, overload. syndr.,   lysine 5,96 g; Methionine 5,13 g; Phenylalanine 9,22 g; Threonine
                                hyperhydrat., pulm.oed.       4,76 g; Tryptophan 1,50 g; Valine 6,76 g; Arginine 7,09 g; Histidine
                                Special precautions: Monit.pts.on coumarin derivats. closely, do   HCl monohydrate 4,44 g equiv.to histidine 3,29 g; Alanine 12,73 g;
   21     AMINO-ACIDS           not mix/infuse concomit.with other sols., caut.in cases of incr.ser.  Aspartic acid 3,94 g; Glutamic acid 9,20 g; Glycine 4,33 g; Proline 8,93
                                osmolarit./ imp. card.or ren.funct., monit./correct disturbs. of fluid,
                                                              g; Serine 7,88 g; NaOH 2,196 g; NaCl 0,710 g; Na acet. trihydr. 0,470
   DIPEPTIVEN (MDR Listing)     electrol./acidbase bal.bef.start of infus., rapid infus.can lead to   g; K acet. 6,917 g; Mg acet.tetrahydr. 1,706 g; CaCl dihydr. 1,168 g.
                                fluid overload with patholog. ser.electrol.conc./hyperhydrat./pulm.
                                                              Each 2500 ml contains: Glucose (anhydr.) 360,0 g equiv.to glucose
   DIPEPTIVEN, Fresenius Kabi [P/S] &  oed., monit.ser.triglycer./bld.gluc.conc., interrupt infus. with S&S of   monohydr. 396,0 g; Na dihydrog. phosph.dihydr. 6,24 g; Zn acetat.di-
   L-alanine 82 g, L-glutamine 134,6 g = (N(2) L-alanyl-L-glutamine)   anaphylact.react., reduc/ interrupt dos. if bld.gluc.conc.&gt; 14 mmol/L   hydr. 17,56 mg; Medium-chain triglycerides 50,0 g; Soybean oil 50,0
   200 g/1 000 ml.              (250 mg /dl), suppl.appropr.replacem.of trace elem.& vits. dur. long-  g; Isoleucine 8,21 g; Leucine 10,96 g; Lysine HCl 9,95 g equiv.to lysine
   Indications: Part of IV parenter.nutrit.regim supplem. amino acid   term.admin., do not giv.simultan.with bld. in same infus.set., fat cont.  7,95 g; Methionine 6,84 g; Phenylalanine 12,29 g; Threonine 6,35 g;
   sol.which do not already contain glutamine.  may interf.with cert. lab.meas.  Tryptophan 2,00 g; Valine 9,01 g; Arginine 9,45 g; Histidine HCl mono-
   (S3) CONC.FOR SOL.FOR INFUS, 33/23/0210  Drug interactions: Heparin in clin.dos.caus. trans. lipoprot.lipase   hydrate 5,92 g equiv.to histidine 4,38 g; Alanine 16,98 g; Aspartic
   882313-002: 1x100 ml, R557,59  releas.into circulat.result.in init. incr.plasma lipolys.follow.by trans.  acid 5,25 g; Glutamic acid 12,27 g; Glycine 5,78 g; Proline 11,90 g;
   Dosage: Not for direct admin. Design.for centr. ven. infus.follow.  triglycer. clear. decr, soybean oil may interf.with therap.eff. of cou-  Serine 10,50 g; NaOH 2,928 g; Nacl 0,946 g; Na acet. trihydr. 0,626
   addit.to compat.carrier sol.1 vol. part.to be mix.with at least 5 vol.  marin derivativ.  g; K acet. 9,222 g; Mg acet.tetrahydr. 2,274 g; CaCl dihydr. 1,558 g.
   parts.carrier sol. (eg 100 ml Dipeptiven + at least 500 ml amino   NUTRIFLEX LIPID PLUS, B Braun [P/S]  Indications: Supply of dly. requirem.of energy, essent. fatty acids,
   acid sol.) Max.fin.conc.not to exceed 3,5%. Durat.of use not to   Each 1875 (2500) ml contains: Glucose (anhydr.) 225,5 (300,0) g   amino acids, electrol. & fluids dur.parenter.nutrit.for pts. with
   exceed 2 wks.                equiv. to glucose monohydr. 247,5 (330,0) g; Na dihydrog.phosph.  mild to mod.sev. catabol.when oral/enter. nutrit.imposs/ insuffic/
   Dos.depend.on sev.of catabol.state & amino acid requirem. Max.  dihydr. 3,51 (4,68) g; Zn acet.dihydr. 9,87 (13,16) mg; Medium-chain   contraindicat.
   dly dos: 2 g amino acid/kg bm in parenter.nutrit. When calculat.con-  triglycerides 37,5 (50,0) g; Soybean oil 37,5 (50,0) g; Isoleucine 4,23   (S3) IV INFUS. 41/25/0759.
   sid.alanine & glutamine suppl.via Dipeptiven.(proport.amino acid   (5,64) g; Leucine 5,64 (7,52) g; Lysine 4,10 (5,46) g equiv.to lysine HCl   716315-001, 625 ml, R478,11
   supplied by Dipeptiven not to exceed approx.30% of tot. supply).  5,12 (6,82) g; Methionine 3,53 (4,70) g; Phenylalanine 6,32 (8,42) g;   716316-001, 1 250 ml, R956,22
   Dly.dos: 1,5-2,5 ml/kg bm (equiv.0,3-0,5 g N(2)-L-alanyl-L-glu-  Threonine 3,27 (4,36) g; Tryptophan 1,02 (1,36) g; Valine 4,68 (6,24)   716318-001, 1 875 ml, R1 434,34
   tamine/kg bm) equat.to 100-175 ml for 70 kg pt. Max.dly.dos:   g; Arginine 4,86 (6,48) g; Histidine 2,25 (3,00) g equiv.to histidine   716320-001, 2 500 ml, R1 912,46
   2,5 ml/kg bm.(equiv. 0,5 g N(2)-L-alanyl-L-glutamine/kg bm) should   HCl monohydr. 3,05 (4,06) g; Alanine 8,73 (11,64) g; Aspartic acid   Dosage: For IV infus., admin.continuous.at max. infus.rate of 1,7
   be admin. in combinat.with at least 1,0 g amino acids/kg bm/ day.   2,70 (3,60) g; Glutamic acid 6,32 (8,42) g; Glycine 2,97 (3,96) g; Pro-  ml/kg body weight/hour, indiv. dose accord.to pt.requirm. Max.dly.
   With amino acids from Dipeptiven incl.this results in dly dos.of at   line 6,12 (8,16) g; Serine 5,40 (7,20) g; NaHCl 1,464 (1,952) g; NaCl   dose: 35 ml/kg body weight.
   least 1,5 g amino acids/kg bm. See prod.lit.for adjustm.examples   0,755 (1,006) g; Na acet.trihydr. 0,416 (0,554) g; K acet. 5,151 (6,868)   Ref.to prod.lit.for sol.prep.
   for the supply with Dipeptiv.& other amino acids through carrier sol.  g; Mg acet.tetrahydr. 1,287 (1,716) g; CaCl dihydr. 0,882 (1,176) g.  Contraindications: Disturbs.of amino acid/lipid metabol., hyperka-
   Contraindications: Sev.ren./hepat.insuffic., metabol. acidos.,   Indications: Supply of dly. requirem.of energy, essent. fatty   laem., hypernatraem., unstab. metabol. e.g. sev.post aggress.syndr./
   safety not demonstr.in pregn./ lactat & childr.  acids, amino acids, electrol. & fluids dur.parenter.nutrit.for pts.with   unstabilis. diabet.mellit./coma of unknown orig., hyperglycaem. not
   Side effects: Chills, N&V if infus.rate exceed.  mild to mod.sev. catabol.when oral/enter.nutrit.imposs/insuffic/   respond.to insul.doses up to 6 unit insul./hr., acidos., intrahepat.cho-
   Warnings and special precautions: Monit.liv. funct. in com-  contraindicate.  lestas., sev. hepat./ren.insuffic., manifest card.insuffic., aggravat.
   pensat.hepat.insuffic.       (S3) IV INFUS. 41/25/0756.    haemorrh.diathes., ac.myocard.infarct.& stroke/thromboembol./lipid
   See also MDR page 347.       716312-001, 1 875 ml, R1 374,58  embol., known hypersens. to egg/soy prot., childr. &lt; 2yrs, unstable
                                716314-001, 2 500 ml, R1 832,77  circulat.stat., inadeq.cellul. O2 supply, fluid overload/ overhydrat.,
                                Dosage: For IV infus., admin.continuous.at max. infus.rate of 2,0   electrol./fluid bal.disturb., ac.pulm.oed./decompensat.card.insuffic.,
   22     SPECIAL FOODS         ml/kg body weight/hr, indiv.dose accord.to pt.requirm. Max.dly.  pregn.& lactat.as safety & effic.not est.
                                dose: 40 ml/kg body weight.
                                                              Side effects: Flush.,incr.temp., cold feel., shiver., headache, loss
                                Ref.to prod.lit.for sol.prep.  of appet., hyperglycaem., bld. disords., N&V, resp.distr., back/
   DEXTROSE FRESENIUS 50 % AMPS, Fresenius Kabi [P/S]  Contraindications: Disturbs. of amino acid/lipid metabol., hyperka-  chest/bone/ lumb.area pain, BP chang., hypersens.reacts, cyanos.,
   Dextr.anhydr.                laem., hypernatraem., unstab. metabol. e.g. sev.post aggress.syndr./  thrombophlebit., septicaemia, local irrit.at inj.site, overload.syndr.,
   Indications: Ac.hypoglycaem., insulin induc. hypoglycaem.coma.  unstabilis. diabet.mellit.coma of unknown orig., hyperglycaem. not   hyperhydrat., pulm.oed.
   (S3) INJ. V/24/222           respond.to insul.doses up to 6 unit insul./hr., acidos., intrahepat.  Special precautions: Monit.pts.on coumarin derivats.closely, do
   782246-001: 10 g/20 ml, 10x20 ml, R264,37  cholestas., sev. hepat./ren.insuffic., manifest card.insuffic., aggrav.   not mix/infuse concomit.with other sols., caut.in cases of incr.ser.
   Dosage: Determ.accord.to pts.requirem. Usual. 50 ml at 10 ml/min.  haemorrh.diathes., ac.myocard.infarct.& stroke/thromboembol./lipid   osmolarit./ imp.card.or ren.funct., monit./correct disturbs.of fluid,
   by centr.venous catheter.    embol., known hypersens. to egg/soy prot., childr. &lt; 2yrs, unstable   electrol./acidbase bal.bef.start of infus., rapid infus.can lead to
   Contraindications: Gluc-galact.malabsorpt. syndr., DT’s with de-  circulat.stat., inadeq. cellul. O2 supply, fluid overload/ overhydrat.,   fluid overload with patholog. ser.electrol.conc./hyperhydrat./ pulm.
   hydrat., intra-cran./intraspin. haemorrh., ac.ischaem.strokes, anur.,   electrol./fluid bal.disturb., ac.pulm.oed./decompensat.card.insuffic.,   oed., monit.ser.triglycer./bld.gluc.conc., interrupt infus.with S&S of
   safety in pregn.& lactat.not est.  pregn.& lactat.as safety & effic.not est.  anaphylact.react., reduc/ interrupt dos. if bld.gluc.conc.&gt; 14 mmol/L
   Side effects: Loc.thrombophlebit, fluid & electrol. imbal., glycosur.  Side effects: Flush., incr.temp., cold feel., shiver., headache ,   (250 mg/dl), suppl.appropr.replacem.of trace elem. & vits. dur.long-
   Special precautions: Diab.insipid., imp.ren. funct., do not mix   loss of appet., hyperglycaem., bld. disords., N&V, resp.distr., back/  term.admin., do not giv.simultan. with bld.in same infus.set., fat
   with bld.                    chest/bone/ lumb.area pain, BP chang., hypersens.reacts, cyanos.,   cont.may interf. with cert.lab.meas.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page354.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page350.html">350</a>&nbsp;&nbsp;&nbsp;<a href="page351.html">351</a>&nbsp;&nbsp;&nbsp;<a href="page352.html">352</a>&nbsp;&nbsp;&nbsp;<a href="page353.html">353</a>&nbsp;&nbsp;&nbsp;<a href="page354.html">354</a>&nbsp;&nbsp;&nbsp;<a href="page355.html">355</a>&nbsp;&nbsp;&nbsp;<a href="page356.html">356</a>&nbsp;&nbsp;&nbsp;<a href="page357.html">357</a>&nbsp;&nbsp;&nbsp;<a href="page358.html">358</a>&nbsp;&nbsp;&nbsp;<a href="page359.html">359</a>&nbsp;&nbsp;&nbsp;<a href="page360.html">360</a>
             </td>
             <td width="35%"><a href="page356.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page356.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
